256 Newsroom — Uganda's Digital News Infrastructure
Business

Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation - STAT

Published by STAT By Andrew Joseph · 7 September 2026 at 14:16
Share
Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation - STAT
Image · STAT

What the report says

Novo Nordisk has stopped two trials of a drug that aims to tame inflammation as a way to improve cardiovascular health, another blow for the approach.

Read the full report at STAT →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting

The 25 years we were never taught to liveThe Observer 256 Newsroom Kenya halts deportations of foreign small-scale traders - monitor.co.ugDaily Monitor Why Uganda wants private money to help transform farmingThe Observer 256 Newsroom Tension as Koboko, Yumbe dispute Araga boundary - monitor.co.ugDaily Monitor 256 Newsroom KCCA’s revenue bet: Help businesses survive, then tax their growth - Daily MonitorDaily Monitor 256 Newsroom Kenya gives foreign traders 90 days to comply - Daily MonitorDaily Monitor